(Reuters) – A panel of the European drugs regulator on Friday recommended approving Merck & Co’s vaccine for the deadly Ebola virus.
The European Medicines Agency said bit.ly/2MrRw4c its human medicines committee (CHMP) has recommended granting a conditional marketing authorization in the European Union for the vaccine, Ervebo, for individuals aged 18 years and older.
Reporting by Pushkala Aripaka in Bengaluru; Editing by Saumyadeb Chakrabarty
Our Standards:The Thomson Reuters Trust Principles.
Source: Reuters.com
